Oncothyreon Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oncothyreon

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Phil Cressman who wrote (613)	4/29/1999 8:06:00 PM
From: Jibacoa	Read Replies (1) of 2344

<<<We could see a fast double.Going to be tough hanging on if the offers get that rich>> Just remember that last November 26 we had a "spike" to the 17 level ( before the Toronto Stock Exchange stopped trading on BRA and the NASDAQ followed). That "spike" was brought on by a positive article on Fortune Magazine. Also remember that the stock price went to 8 when the FDA approved Biomira's test for breast cancer, which was later sold when the company disposed of their diagnostic division to concentrate on the Ca. vaccines, which they felt had a more rewarding potential. You may have problems "holding" if the price doubles from present levels, but $9 is still too low a target and not a "rich offer" for long holders of BIOM.!!! Good luck to all.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next